Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

[1]  Kelsey K. Finn,et al.  Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19 , 2020, Cell.

[2]  C. Harrison.  Focus shifts to antibody cocktails for COVID-19 cytokine storm , 2020, Nature Biotechnology.

[3]  Eric Song,et al.  Longitudinal analyses reveal immunological misfiring in severe COVID-19 , 2020, Nature.

[4]  J. Sodroski,et al.  Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike , 2020, Nature.

[5]  Otto O. Yang,et al.  Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19 , 2020, The New England journal of medicine.

[6]  Sasikanth Manne,et al.  Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications , 2020, Science.

[7]  Lisa E. Gralinski,et al.  Potently neutralizing and protective human antibodies against SARS-CoV-2 , 2020, Nature.

[8]  R. Sanders,et al.  Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage hyper-inflammatory responses , 2020, bioRxiv.

[9]  Zhenghao Xu,et al.  Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies , 2020, Frontiers in Immunology.

[10]  Angelo Carfì,et al.  Persistent Symptoms in Patients After Acute COVID-19. , 2020, JAMA.

[11]  Huadong Zhu,et al.  Brief Report: Anti-phospholipid antibodies in critically ill patients with Coronavirus Disease 2019 (COVID-19). , 2020, Arthritis & rheumatology.

[12]  Immunomodulation for the management of corona virus disease (COVID-19) , 2020, Transfusion and Apheresis Science.

[13]  Jennifer L. Bell,et al.  Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report , 2020, medRxiv.

[14]  J. Sodroski,et al.  Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike , 2020, bioRxiv.

[15]  X. Tang,et al.  Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections , 2020, Nature Medicine.

[16]  Vineet D. Menachery,et al.  Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients , 2020, Cell Reports Medicine.

[17]  R. Dudley,et al.  Immunomodulation in COVID-19 , 2020, The Lancet Respiratory Medicine.

[18]  N. Baumgarth,et al.  B Cell Activation and Response Regulation During Viral Infections. , 2020, Viral immunology.

[19]  Dong Men,et al.  Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019 , 2020, Clinical Infectious Diseases.

[20]  Stefano Volpi,et al.  On the Alert for Cytokine Storm: Immunopathology in COVID‐19 , 2020, Arthritis & rheumatology.

[21]  Xiaowei Yan,et al.  Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 , 2020, The New England journal of medicine.

[22]  I. Wilson,et al.  A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV , 2020, Science.

[23]  Hongming Miao,et al.  Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study , 2020, Signal Transduction and Targeted Therapy.

[24]  D. Watkins,et al.  Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine , 2020, Proceedings of the National Academy of Sciences.

[25]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[26]  Xiao-Neng Mo,et al.  Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients , 2020, Emerging microbes & infections.

[27]  Peter D. Pioli.  Plasma Cells, the Next Generation: Beyond Antibody Secretion , 2019, Front. Immunol..

[28]  Scott A. Jenks,et al.  Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations , 2019, Front. Immunol..

[29]  Huji Xu,et al.  Excessive CD11c+Tbet+ B cells promote aberrant TFH differentiation and affinity-based germinal center selection in lupus , 2019, Proceedings of the National Academy of Sciences.

[30]  Paul A. Harris,et al.  The REDCap consortium: Building an international community of software platform partners , 2019, J. Biomed. Informatics.

[31]  Christopher D. Scharer,et al.  Epigenetic programming underpins B cell dysfunction in human SLE , 2019, Nature Immunology.

[32]  Christopher D. Scharer,et al.  IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation , 2019, bioRxiv.

[33]  Ravi S. Misra,et al.  T-bet Transcription Factor Promotes Antibody-Secreting Cell Differentiation by Limiting the Inflammatory Effects of IFN-γ on B Cells. , 2019, Immunity.

[34]  D. Allman,et al.  The continuing story of T‐cell independent antibodies , 2019, Immunological reviews.

[35]  I. Sanz,et al.  Extrafollicular responses in humans and SLE , 2019, Immunological reviews.

[36]  Lai Guan Ng,et al.  Dimensionality reduction for visualizing single-cell data using UMAP , 2018, Nature Biotechnology.

[37]  Peng Qiu,et al.  GLaMST: grow lineages along minimum spanning tree for b cell receptor sequencing data , 2018, BMC Genomics.

[38]  G. Gibson,et al.  Distinct Effector B Cells Induced by Unregulated Toll‐like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus , 2018, Immunity.

[39]  Xiaoyang Liu,et al.  FMST: an Automatic Neuron Tracing Method Based on Fast Marching and Minimum Spanning Tree , 2018, Neuroinformatics.

[40]  I. Sanz,et al.  Understanding B‐cell activation and autoantibody repertoire selection in systemic lupus erythematosus: A B‐cell immunomics approach , 2018, Immunological reviews.

[41]  S. Rahman,et al.  IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE , 2018, Nature Communications.

[42]  T. Rimmele,et al.  Septic Shock Shapes B Cell Response toward an Exhausted-like/Immunoregulatory Profile in Patients , 2018, The Journal of Immunology.

[43]  R. Jessberger,et al.  Regulation of Age-associated B cells by IRF5 in systemic autoimmunity , 2018, Nature Immunology.

[44]  A. Shalek,et al.  Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells , 2017, Cell.

[45]  Lingling Wu,et al.  T-bet+CD11c+ B cells are critical for antichromatin immunoglobulin G production in the development of lupus , 2017, Arthritis Research & Therapy.

[46]  P. Marrack,et al.  B cells expressing the transcription factor T-bet drive lupus-like autoimmunity , 2017, The Journal of clinical investigation.

[47]  C. Goodnow,et al.  Clonal redemption of autoantibodies by somatic hypermutation away from self-reactivity during human immunization , 2016, The Journal of experimental medicine.

[48]  P. M. Davis,et al.  B cells from African American lupus patients exhibit an activated phenotype. , 2016, JCI insight.

[49]  P. Marrack,et al.  Age-Associated B Cells: A T-bet–Dependent Effector with Roles in Protective and Pathogenic Immunity , 2015, The Journal of Immunology.

[50]  E. Meffre,et al.  Salmonella Infection Drives Promiscuous B Cell Activation Followed by Extrafollicular Affinity Maturation. , 2015, Immunity.

[51]  P. Marrack,et al.  CD11c-Expressing B Cells Are Located at the T Cell/B Cell Border in Spleen and Are Potent APCs , 2015, The Journal of Immunology.

[52]  Ivan V. Gregoretti,et al.  Diversity, cellular origin and autoreactivity of antibody-secreting cell expansions in acute Systemic Lupus Erythematosus , 2015, Nature Immunology.

[53]  B. Pulendran,et al.  Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation. , 2014, Cell host & microbe.

[54]  V. D. Dang,et al.  From the regulatory functions of B cells to the identification of cytokine-producing plasma cell subsets. , 2014, Current opinion in immunology.

[55]  T. Singh,et al.  B cells mediate chronic allograft rejection independently of antibody production. , 2014, The Journal of clinical investigation.

[56]  Ravi S. Misra,et al.  Unraveling effector functions of B cells during infection: the hidden world beyond antibody production. , 2012, Infectious disorders drug targets.

[57]  B. Pulendran,et al.  Rapid and Massive Virus-Specific Plasmablast Responses during Acute Dengue Virus Infection in Humans , 2012, Journal of Virology.

[58]  M. Dougados,et al.  Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis. , 2011, Arthritis and rheumatism.

[59]  E. Walsh,et al.  Circulating Human Antibody-Secreting Cells during Vaccinations and Respiratory Viral Infections Are Characterized by High Specificity and Lack of Bystander Effect , 2011, The Journal of Immunology.

[60]  J. Pérez-Venegas,et al.  Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients , 2010, Arthritis research & therapy.

[61]  T. Randall,et al.  Effector and regulatory B cells: modulators of CD4+ T cell immunity , 2010, Nature Reviews Immunology.

[62]  Shuying Wang,et al.  Annexin A2 on lung epithelial cell surface is recognized by severe acute respiratory syndrome-associated coronavirus spike domain 2 antibodies , 2009, Molecular Immunology.

[63]  Jaap Goudsmit,et al.  Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants , 2006, PLoS medicine.

[64]  Chad W. Euler,et al.  Evolution of Autoantibody Responses via Somatic Hypermutation Outside of Germinal Centers , 2002, Science.

[65]  M. Shlomchik,et al.  A Novel Mouse with B Cells but Lacking Serum Antibody Reveals an Antibody-independent Role for B Cells in Murine Lupus , 1999, The Journal of experimental medicine.